| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2005-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2008-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2008516898-A |
| titleOfInvention |
4- (4-Methylpiperazin-1-ylmethyl) -N- [4-methyl-3- (4- (pyridin-3-yl) pyrimidin-2-ylamino) for inhibiting the tyrosine kinase receptor c-fms Use of phenyl] -benzamide |
| abstract |
The present invention relates to 4- (4-methylpiperazin-1-ylmethyl) -N- [4-methyl-3- (4- (pyridin-3-yl) for the manufacture of a medicament for the treatment of c-fms related diseases. It relates to the use of pyrimidin-2-ylamino) phenyl] -benzamide (Compound I) or a pharmaceutically acceptable salt thereof. |
| priorityDate |
2004-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |